Specialty Pharma Journal Specialty, Precision & Technology
LONDON–(BUSINESS WIRE)–Celltrion Healthcare outlined their vision of ‘shaping future healthcare by improving access to biosimilars’ at the 5th Annual Biosimilars USA Conference in New Jersey, US. Biosimilars offer healthcare providers and patients greater treatment choice and value, better access to treatments and improved patient outcomes. According to data provided by IMS …
Tag Archives: Drug Spend
November, 2018
May, 2018
-
23 May
Biosimilars Could Facilitate Early Access to Life Changing Biological Treatments for Patients
BALTIMORE–(BUSINESS WIRE)–At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring …
December, 2017
-
4 December
CVS Health to Acquire Health Insurer Aetna for $69 Billion
WOONSOCKET, R.I. and HARTFORD, Conn., Dec. 3, 2017 /PRNewswire/ — CVS Health (NYSE: CVS), a company at the forefront of changing the health care landscape, and Aetna (NYSE: AET), one of the nation’s leading diversified health care benefits companies, today announced the execution of a definitive merger agreement under which CVS Health will acquire …
May, 2017
-
5 May
US Drug Spending Growth of 4.8 Percent in 2016 According to QuintilesIMS Institute Study
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Growth in U.S. spending on prescription medicines fell in 2016 as competition intensified among manufacturers, and payers ramped up efforts to limit price increases, according to research released today by the QuintilesIMS Institute. New medicines introduced in the past two years continue to …
April, 2017
-
3 April
Medical Pharmacy Trend Report Highlights Member and Payer Impact of High-Cost Specialty Drugs Billed on the Medical Benefit
SCOTTSDALE, Ariz.–(BUSINESS WIRE)– Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) today released its seventh annual Medical Pharmacy Trend Report, which continues to be a leading source for payers and other industry stakeholders to analyze high-cost injectable drugs paid under the medical benefit. …
December, 2016
-
6 December
Global Drug Market will Reach Nearly $1.5 Trillion in 2021 as Spending Growth Moderates
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Total spending on medicines is forecast to reach $1.5 trillion by 2021, up 33 percent from 2016 levels, even as annual growth moderates from the record pace set in 2014 and 2015, according to new research released today by the QuintilesIMS Institute. While …
October, 2016
-
3 October
Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled
ST. PAUL, MINN. – Sept. 30, 2016 –In the past four years, spending on autoimmune drugs has doubled and utilization has jumped nearly 40 percent in a population of 4.4 million commercially-insured members, according to new research from Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving more than 22 …
June, 2016
-
15 June
New Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars? According to a new study published in the International Journal of Epidemiology this week, genetic research …
March, 2016
-
9 March
Smoothing the Path
Medication adherence continues to be a challenge for the health care community. Successful treatment of disease simply cannot occur if patients are not adherent to medications. In addition, non-adherence leads to systemic waste. For example, up to 10% of all money spent on health care is attributed to avoidable health …
January, 2016
-
11 January
New Report Finds Prescription Drug Prices Rose 10.43 Percent in 2015
NEW YORK–(BUSINESS WIRE)–Amidst increasing consumer concerns and mounting scrutiny from lawmakers, a new report indicates prescription drug prices rose 10.43 percent in 2015 – continuing to squeeze American household budgets and adding fuel to the debate surrounding soaring healthcare costs. The figures were released as part of the OneRx® National …